Products & Services

Available Now: An Expanded Range of
MyCell® Disease Lines

Disease-relevant Backgrounds – In the Cell Types You Want

Available September 2015 from CDI: Differentiated cells produced from two of the largest patient-derived iPS cell collections, representing the following diseases (with more disease samples and isogenic controls coming soon):

ddp_table2

MyCell Disease and Diversity Products – Leveraging iPS Cell Collections for the Disease Models You Want

The Process: Samples from donors representing a range of diseases and controls were reprogrammed using a footprint-free method, expanded and banked at the Coriell Institute and the WiCell Research Institute. Cellular Dynamics differentiates your selected iPSC lines from these collections to provide the desired disease-specific and control tissue cells suited to a broad range of drug discovery, toxicology, and regenerative medicine applications.

The Process:
Samples from donors representing a range of diseases and controls were reprogrammed using a footprint-free method, expanded and banked at the Coriell Institute and the WiCell Research Institute. Cellular Dynamics differentiates your selected iPSC lines from these collections to provide the desired disease-specific and control tissue cells suited to a broad range of drug discovery, toxicology, and regenerative medicine applications.